CANCER INSTITUTE - liveagain

CANCER INSTITUTE

CANCER INSTITUTE  

In 2006, AMC established Korea’s first multidisciplinary cancer institute, initiating its comprehensive approach to cancer treatment. At the institute, specialists in diagnostic, surgical, medical, and radiation oncology collaborate to develop individualized care plans for each patient. The institute has conducted the largest number of cancer surgeries in Korea and has provided customized cancer treatment through its Center for Personalized Cancer Medicine.  

 

 

16 SUB-CENTERS 

Liver Cancer Center  

Brain Tumor Center  

Skin Cancer Center  

Lung Cancer Center 

Colon Cancer Center  

CAR T-Cell Therapy Center 

Breast Cancer Center 

Urologic Cancer Center 

Stomach Cancer Center 

Esophageal Cancer Center 

Gynecologic Cancer Center 

Head & Neck Cancer Center 

Biliary & Pancreatic Cancer Center  

Hematologic Cancer & BMT Center  

Sarcoma & Rare Cancer Center 

Center for Personalized Cancer Medicine  

 

SIGNIFICANT ACHIEVEMENTS 

  • World’s largest number of gastric cancer cases treated
  • World’s largest number of cervical cancer laparoscopic surgeries conducted
  • Korea’s largest number of cancer surgeries conducted annually (especially liver cancer, pancreatic and biliary cancer, colon cancer, breast cancer) •Korea’s first multidisciplinary cancer center (2006) 
  • World’s first emergency center designated for cancer patients only (2009)
  • Korea’s first personalized cancer medicine center (2012)
  • Korea’s first precision medicine platform (2020) •Over 1 million cancer patients (2020)
  • Approximately 30% of face-to-face multidisciplinary integrated treatment in Korea (2020)
  • 500 cases of esophageal cancer robotic surgery (the most significant number in Asia) (2021)

 

CENTER FOR PERSONALIZED CANCER MEDICINE 

The Center for Personalized Cancer Medicine (CPCM) opened in 2012, first in Korea. Medical oncologists refer metastatic cancer patients to the CPCM for genomic aberration profiling and matching, to identify potential targeted therapies available on the market or under clinical trials.

 

MULTIDISCIPLINARY CANCER CLINIC 

“Korea’s first and largest Multidisciplinary Cancer Center” 

Features 

  • 29 Sessions in the Multidisciplinary Cancer Clinics
  • 5,472 Patients (2021)
  • 284 Medical Staffs

PRECISION MEDICINE IN ASAN CANCER INSTITUTE 

  • In 2011, ASAN Center for Cancer Genome Discovery(ASAN-CCGD) with 1,400 gene mutations of diverse tumor was established as AMC contracted with Dana-Farber Cancer Institute (DFCI)
  • NGS genomic testing covered by the National Health Insurance (March 1st, 2017) •No.1 for Number of NGS in Korea

 

CAR T-CELL THERAPY CENTER 

The CART Cell Therapy Center at Asan Medical Center comprises medical staff with abundant experience in blood cancer treatment and hematopoietic stem cell transplantation and is based on the latest knowledge. We would like to give new hope to B cell lymphoma patients under the age of 25. 

Related articles